ABSTRACT
A 12-year-old mixed breed dog was evaluated for marked hypercalcemia that was identified during assessment for acute polydipsia and polyuria. Physical examination identified a new grade II/VI left apical systolic murmur. A mass involving the left ventricular posterior wall and left atrium was identified by echocardiography, suggesting neoplastic invasion into the myocardium. The patient was euthanized, and post-mortem cardiac evaluation identified an intramyocardial amyloid-producing plasma cell tumor. Multiple myeloma was suspected but could not be confirmed due to the limited post-mortem evaluation. This case is the first report of myocardial amyloidosis in a dog with a myeloma-related disorder (MRD). Dogs with MRD and myocardial involvement may not exhibit clinical signs that localize to the cardiovascular system; therefore, echocardiography should be considered during the staging process.
Subject(s)
Amyloidosis , Dog Diseases , Plasmacytoma , Dogs , Animals , Plasmacytoma/pathology , Plasmacytoma/veterinary , Myocardium/pathology , Heart , Amyloidosis/diagnosis , Amyloidosis/veterinary , Amyloidosis/pathology , Echocardiography/veterinary , Dog Diseases/diagnostic imaging , Dog Diseases/pathologyABSTRACT
In many ecosystems, especially aquatic ecosystems, size plays a critical role in the factors that determine an individual's ability to survive and reproduce. In aquatic ecotoxicology, size informs both realized and potential acute and chronic effects of chemical exposure. This paper demonstrates how chemical and nonchemical effects on growth, survival, and reproduction can be linked to population-level dynamics using size-structured integral projection models (IPM). The modeling approach was developed with the goals and constraints of ecological risk assessors in mind, who are tasked with estimating the effects of chemical exposures to wildlife populations in a data-limited environment. The included case study is a collection of daily time-step IPMs parameterized for the life history and annual cycle of fathead minnows (Pimephales promelas), which motivated the development of modeling techniques for seasonal, iteroparous reproduction, density dependent growth effects, and size-dependent over-winter survival. The effects of a time-variable annual chemical exposure were interpreted using a toxicokinetic-toxicodynamic model for acute survival and sub-lethal growth effects model for chronic effects and incorporated into the IPMs. This paper presents a first application of integral projection models to ecotoxicology. Our research demonstrates that size-structured IPMs provide a promising, flexible, framework for synthesizing ecotoxicologically relevant data and theory to explore the effects of chemical and nonchemical stressors and the resulting impacts on exposed populations.
ABSTRACT
INTRODUCTION: To determine whether oral l-arginine increases plasma [l-citrulline] in dogs. ANIMALS: Eleven healthy staff-owned dogs were used in this study. MATERIALS AND METHODS: Dogs (n = 3) were given l-arginine (50mg/kg PO q8h) for 7 days, and plasma [l-arginine] and [l-citrulline] were analyzed by high performance liquid chromatography at baseline (BL), steady state trough, and 0.5, 1, 1.5, 2, 4, 6, and 8 h after final dosing on day 7. Eleven dogs were then treated with 100mg/kg l-arginine PO q8h for 7 days, and [l-arginine] and [l-citrulline] were measured at BL, steady state trough, and at peak 4 hrs after dosing (T4 hrs). RESULTS: - Plasma [l-arginine] and [l-citrulline] peaked at T4 hrs on the 50mg/kg dosage. Target outcome, modeled after human study results, of a doubling of [l-arginine] and a 25-30% increase in [l-citrulline] from BL were not reached. After the 100mg/kg dosage, plasma [l-arginine] increased from a BL median of 160.1 µM (range, 100.2-231.4 µM) to a peak of 417.4 µM (206.5-807.3 µM) at T4 hrs, and plasma [l-citrulline] increased from a BL median of 87.8 µM (59.1-117.1 µM) to peak of 102.2 µM (47.4-192.6 µM) at T4 hrs. Ten of eleven dogs showed a doubling of plasma [l-arginine] and 4/11 dogs achieved 25-30% or greater increases in plasma [l-citrulline]. No adverse effects on heart rate or blood pressure were noted. CONCLUSIONS: - Oral l-arginine dosage of 100mg/kg q8h doubles plasma [l-arginine] in healthy dogs, but conversion to l-citrulline is quite variable. Further evaluation of this dosage regimen in dogs with pulmonary hypertension is warranted.
Subject(s)
Arginine/administration & dosage , Citrulline/blood , Dogs/blood , Animals , Blood Pressure , Female , Male , Nitric OxideABSTRACT
A method is presented to test whether the conversion of the mass spectrum of a polydisperse analyte to its molecular mass distribution is quantitative. Mixtures of samples with different average molecular masses, coupled with a Taylor's expansion mathematical formalism, were used to ascertain the reliability of molecular mass distributions derived from mass spectra. Additionally, the method describes how the molecular mass distributions may be corrected if the degree of mass bias is within certain defined limits. This method was demonstrated on polydisperse samples of C(60) fullerenes functionalized with ethylpyrrolidine groups measured by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; however, it is applicable to any polydisperse analyte and mass spectrometric method as long as spectrum resolution allows individual oligomers to be identified. Mass spectra of the derivatized fullerenes taken in positive ion mode were shown to give an accurate measurement of the molecular mass distribution while those taken in negative ion mode were not. Differences in the mechanisms for ion formation are used to explain the discrepancy. Official contribution of the National Institute of Standards and Technology; not subject to copyright in the United States of America.
Subject(s)
Algorithms , Fullerenes/analysis , Fullerenes/chemistry , Models, Chemical , Molecular Weight , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Computer SimulationABSTRACT
The polydispersity in the degree of functionalization for two calix[4]resorcinarenes was determined by measuring quantitatively their molecular mass distribution with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. A mathematical method for polydisperse materials is described that creates a calibration curve to correct the ion signal intensities in the mass spectrum to give a more reliable molecular mass distribution. Correction is required due to various sample preparation and instrumental effects that may produce a systematic mass bias in the number of oligomers measured. This method employs gravimetric mixtures of analytes with different degrees of functionalization. One calix[4]resorcinarene was found to give accurate molecular mass distributions with little correction, while another, having a very similar molecular structure, was found to exhibit strong over-counting of the oligomers having a high degree of functionalization.
ABSTRACT
A novel approach is described for the selection of optimal instrument parameters that yield a mass spectrum which best replicates the molecular mass distribution of a synthetic polymer. The application of implicit filtering algorithms is shown to be a viable method to find the best instrument settings while simultaneously minimizing the total number of experiments that need to be performed. This includes considerations of when to halt the iterative optimization process at a point when statistically-significant gains can no longer be expected. An algorithm to determine the confidence intervals for each parameter is also given. Details on sample preparation and data analysis that ensure stability of the measurement over the time scale of the optimization experiments are provided. This work represents part of an effort to develop an absolute molecular mass distribution polymer Standard Reference Material.
ABSTRACT
Methoxychlor is an insecticide with estrogen-like activity, thus exposure during development might cause sexually dimorphic behavioral alterations. To evaluate this, pregnant rats consumed diets containing 0, 10, 100 or 1000 ppm methoxychlor from gestational day 7, and offspring continued on these diets until postnatal day (PND) 77. Assessments of sexually dimorphic behaviors in offspring indicated that intake of a 3.0% sodium chloride solution was significantly increased (41%) in males and females of the 1000 ppm group. No treatment group differed from controls in open field nor running wheel activity, play behavior, nor 0.3% saccharin solution intake. Offspring of the 1000 ppm group showed significantly decreased body weight, reaching 17% less than controls at PND 77, but not clearly related to their salt solution intake. During pregnancy, 1000 ppm dams consumed 23% less food and weighed 10% less than controls, but this did not affect litter outcomes. These results indicate that in rodents, developmental and chronic exposure to dietary methoxychlor alters the sexually dimorphic behavior of salt-solution intake in young adults of both sexes. Similar behavioral alterations with other xenoestrogens, and the potential for interactions among xenoestrogens, suggest that this report may minimize the true effects of dietary methoxychlor exposure.
Subject(s)
Behavior, Animal/drug effects , Food Preferences/drug effects , Insecticides/toxicity , Methoxychlor/toxicity , Sodium, Dietary , Animals , Birth Weight/drug effects , Body Weight/drug effects , Diet , Eating/drug effects , Female , Male , Motor Activity/drug effects , Play and Playthings , Pregnancy , Rats , Rats, Sprague-Dawley , Reproduction/drug effects , Sex CharacteristicsABSTRACT
The toxicity of the mycotoxins nivalenol (NIV), deoxynivalenol (DON) and fumonisin B1 (FB1) were studied in the K562 human erythroleukemia cell line using the Trypan Blue, MTT and BrdU uptake analyses of cytotoxicity, cell metabolism and cell proliferation, respectively. Nuclear staining with propidium iodide and DNA analysis by flow cytometry were used to identify apoptosis and cell cycle distribution. By the MTT and BrdU tests, both NIV and DON were significantly more toxic than FB1 by at least one order of magnitude, with ID50s ranging from 0.5 microM for NIV to 70 microM for FB1. The MTT test indicated that NIV was significantly (approximately four times) more toxic than DON. In contrast, the Trypan Blue test did not reveal any effects of mycotoxin exposure suggesting that, at the concentrations tested, NIV, DON and FB1 did not induce cytotoxicity through plasma membrane damage. Cell cycle analysis suggested apoptotic cytotoxicity, revealing 100% cellular debris at the highest concentrations of NIV and DON and approximately 2.9 times more debris than control at the highest FB1 concentration. Morphological evidence of apoptosis was related to the toxicity of the substances, such that the more toxic NIV and DON resulted in more late stage apoptotic events than FB1. This study suggests that human blood cells are sensitive to mycotoxin exposure, that NIV is more toxic than DON which is more toxic than FB1, and that DNA damage and apoptosis rather than plasma membrane damage and necrosis may be responsible for the observed cytotoxicity.
Subject(s)
Apoptosis/drug effects , Fumonisins/adverse effects , Leukemia, Erythroblastic, Acute/pathology , Mycotoxins/adverse effects , Trichothecenes/adverse effects , Bromodeoxyuridine/metabolism , Bromodeoxyuridine/pharmacology , Cell Cycle/drug effects , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Membrane/drug effects , Cell Membrane/physiology , Cell Physiological Phenomena/drug effects , Cell Survival/drug effects , Cell Survival/physiology , Cycloheximide/adverse effects , DNA Replication/drug effects , Dose-Response Relationship, Drug , Flow Cytometry/methods , Humans , K562 Cells , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondria/pathology , Tetrazolium Salts/metabolism , Tetrazolium Salts/pharmacology , Thiazoles/metabolism , Thiazoles/pharmacology , Trypan Blue/metabolism , Trypan Blue/pharmacologyABSTRACT
Vinclozolin is a fungicide used on food crops with human exposure estimated at approximately 2 microg/kg/day from ingestion; occupational exposure, however, may be greater. The metabolites of vinclozolin have been reported to act as antiandrogens and have adverse effects on reproductive physiology and behavior in animals. Here, pregnant rats were fed soy-free diets containing 0, 10, 150, or 750 ppm of vinclozolin (approximately 0, 0.8, 12, and 60 mg/kg/day for an adult) beginning on gestational day 7, and offspring were continued on these diets through sacrifice at postnatal day 77. Male and female offspring were assessed for changes in several nonreproductive sexually dimorphic behaviors: open field and running wheel locomotor activity, play behavior, and consumption of saccharin- and sodium chloride-flavored solutions. There was a significant interaction of sex with vinclozolin exposure on running wheel activity, which indicated that females in the high-dose exposure group were hypoactive compared to same-sex controls. There was a significant overall effect of vinclozolin exposure on fluid consumption, and high-dose animals showed increased intake of the saccharin solution and decreased intake of plain water while saccharin was available. Effects were more pronounced in females, which drank 40.8% more saccharin than control females, whereas males drank 6.2% more than control males. There were no effects of vinclozolin treatment on play behavior or sodium solution intake. Gestational duration, total and live pups per litter, litter sex ratios, and birth weight were also not significantly affected, nor were body weight and food intake for dams and offspring. These results indicate that long-term dietary exposure to vinclozolin does not have severe toxicological consequences on the nonreproductive behaviors measured here. However, exposure may cause subtle alterations in locomotor activity and consumption of saccharin-flavored solution.
Subject(s)
Behavior, Animal/drug effects , Fungicides, Industrial/toxicity , Maternal Behavior/drug effects , Motor Activity/drug effects , Oxazoles/toxicity , Prenatal Exposure Delayed Effects , Administration, Oral , Animal Feed , Animals , Body Weight/drug effects , Drinking Behavior/drug effects , Female , Fungicides, Industrial/administration & dosage , Humans , Male , Oxazoles/administration & dosage , Pregnancy , Rats , Rats, Sprague-Dawley , SaccharinABSTRACT
Nonylphenol ethoxylates are used in the production of surfactants and are found in numerous manufactured substances. para-Nonylphenol (NP) is a suspected endocrine disruptor, exhibiting estrogen-like activity and might cause alterations with developmental exposure. To evaluate such effects, pregnant Sprague-Dawley rats consumed diets containing 0 (n = 11), 25 (n = 10), 500 (n = 10), or 2,000 (n = 9) ppm NP beginning on gestational day (GD) 7. At postnatal day (PND) 21, offspring continued on the same maternal diets until PND 77 and were evaluated for behavioral alterations (open-field activity at PNDs 22-24, 43-45, 64-66, play behavior at PND 35, running wheel activity at PND 63-77, flavored solution intake at PND 69-75). During pregnancy and lactation, dams in the 25-, 500-, and 2,000-ppm groups consumed 9 to 25% less food, which was associated with a 17% less weight gain during GDs 1 to 21 in dams of the 2,000-ppm group, although this effect was not statistically significant. Gestation duration, birth weight, sex ratio of live pups, and number of live or dead pups per litter did not differ between treatment groups. Offspring body weight and food consumption were decreased in the 2, 000-ppm group beginning at PND 28; however, an effect of feed aversion could not be eliminated. Behavioral assessments of offspring indicated no consistent NP-related effects in open-field activity at PNDs 22-24, 43-45, and 65-67 nor in running wheel activity at PNDs 63-75. Play behavior at PND 35 and intake of a 0.3% saccharin-flavored solution at PNDs 69-71 did not differ with respect to treatment groups. However, intake of a 3% sodium-flavored solution at PNDs 73-75 was significantly increased in offspring of the 2,000-ppm group and intake of regular water during this same time was also significantly increased. These results indicate that developmental NP treatment results in maternal and offspring toxicity as evidenced by decreased food intake and weight gain. However, behavioral alterations were evident only in increased intake of a sodium solution.
Subject(s)
Behavior, Animal/drug effects , Phenols/toxicity , Prenatal Exposure Delayed Effects , Animals , Body Weight/drug effects , Dose-Response Relationship, Drug , Drinking Behavior/drug effects , Eating/drug effects , Female , Male , Motor Activity/drug effects , Pregnancy , Pregnancy Outcome , Rats , Rats, Sprague-Dawley , Sex FactorsABSTRACT
The phytoestrogen genistein, the principal isoflavone in soybeans, has adverse effects on animal reproduction. As adult physiology and behavior are sensitive to perturbation by developmental estrogens, exposure to genistein during development may produce behavioral alterations as well. Pregnant rats were fed soy-free diets containing 0, 25, 250, or 1250 ppm genistein (approximately 0, 2, 20, or 100 mg/kg/day) beginning on gestational day 7, and offspring continued on these diets through postnatal day (PND) 77. Male and female offspring were assessed for levels of sexually dimorphic behaviors: open field activity, play behavior, running wheel activity, and consumption of saccharin- and sodium chloride-flavored solutions. Consumption of the salt solution was affected by genistein, with animals in the 1250-ppm group drinking significantly more than controls; consumption of plain water was unaffected. Genistein treatment also significantly affected play behavior; although no treated group was significantly different from controls, and the effect was not sexually dimorphic. Running wheel activity and saccharin solution consumption showed significant sex differences, but no effects of genistein treatment. Gestational duration, total and live pups per litter, and total and live litter sex ratios were not significantly affected by genistein. However, average weight per live pup at birth and offspring body weights from PND 42-77 were significantly decreased in the 1250-ppm group. Body weight and food intake for the dams were also significantly decreased in the 1250-ppm group. These results indicate that developmental genistein treatment, at levels that decrease maternal and offspring body weight, causes subtle alterations in some sexually dimorphic behaviors.
Subject(s)
Genistein/pharmacology , Growth Inhibitors/pharmacology , Sex Characteristics , Sexual Behavior, Animal/drug effects , Animals , Animals, Newborn , Body Weight/drug effects , Eating/drug effects , Endocrine System Diseases/chemically induced , Feeding Behavior/drug effects , Female , Male , Maternal Exposure , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Rats, Sprague-Dawley , Reproduction/drug effectsABSTRACT
A number of different environmental compounds are proposed to interact with the endocrine system (i.e., endocrine disrupters). Many of these have estrogenic effects in vitro and/or in vivo. Recent reviews have focused attention on the need for assessing the neurotoxicity of these compounds following developmental exposure. This attention comes in part from the literature on the effects of developmental exposure to exogenous estrogen on later behavioral and neuropathological alterations. A review of the ongoing neurobehavioral and neuropathological studies at the National Center for Toxicological Research on four such estrogen mimics (genistein, methoxychlor, nonylphenol, and ethinyl estradiol) is presented with results indicating that intake of a sodium solution is sensitive to these estrogen mimics. Developmental dietary exposure in male and female rats resulted in increased consumption of the sodium solution. Volume of the sexually dimorphic nucleus of the medial preoptic area was reduced by genistein, nonylphenol, and ethinyl estradiol exposure in males. The regulatory impact of these data and the directions for future research are discussed.
Subject(s)
Endocrine Glands/drug effects , Endocrine Glands/growth & development , Estradiol Congeners/toxicity , Neurotoxicity Syndromes/pathology , Animals , Female , Humans , Nervous System/drug effects , Pregnancy , Sex CharacteristicsABSTRACT
The phytoestrogen and principal isoflavone in soy, genistein, has adverse effects on reproductive physiology in rodents. Since physiology and behavior are both sensitive to perturbations by estrogens, genistein may produce behavioral alterations as well. This paper reports one aspect of a study in which several adult rodent behaviors will be assessed following long term multigenerational dietary exposure to genistein. Since maternal care may affect offspring behaviors in adulthood, it is important to determine the potential for genistein to affect maternal behavior. Here, rats (F0 generation) were fed soy-free diets containing 0, 5, 100, or 500 ppm genistein (approx. 0, 0.4, 8, and 40 mg/kg/day for an adult) beginning on postnatal day (PND) 42. Two generations of offspring (F1 and F2) were continued on these diets and all treatment groups of the F3 generation were returned to 0 ppm at weaning (PND 22). In the first 3 weeks after parturition (for each generation), dams were assessed on 6 occasions for the presence of the arched back posture with at least one pup nursing. Data were analyzed by 3 way repeated measures analysis of variance (ANOVA) with generation, treatment, and postnatal day as factors, and p<0.05 required for significance. There were no significant interactions among treatment, generation, or day, and no overall effects of treatment or generation. As expected, there was a significant overall effect of day, with animals nursing less on later days (p<0.0001). As assessed here, these results suggest that lifelong and multigenerational exposure to dietary genistein has no severe effects on nursing behavior in rodents.
Subject(s)
Anticarcinogenic Agents/toxicity , Estrogens, Non-Steroidal/toxicity , Genistein/toxicity , Isoflavones , Lactation/drug effects , Animals , Behavior, Animal/drug effects , Diet , Female , Male , Phytoestrogens , Plant Preparations , Rats , Rats, Sprague-DawleyABSTRACT
This study investigated age- and gender-specific variations in properties of the glutamate N-methyl-d-aspartate receptor (NMDAR) in a freshwater teleost, the platyfish (Xiphophorus maculatus). Prior localization of the immunoreactive (ir)-R1 subunit of the NMDAR protein (R1) in cells of the nucleus olfactoretinalis (NOR), a primary gonadotropin-releasing hormone (GnRH)-containing brain nucleus in the platyfish, suggests that NMDAR, as in mammals, is involved in modulation of the platyfish brain-pituitary-gonad (BPG) axis. The current study shows that the number of cells in the NOR displaying ir-R1 is significantly increased in pubescent and mature female platyfish when compared to immature and senescent animals. In males, there is no significant change in ir-R1 expression in the NOR at any time in their lifespan. The affinity of the noncompetitive antagonist ((3)H)MK-801 for the NMDAR is significantly increased in pubescent females while maximum binding of ((3)H)MK-801 to the receptor reaches a significant maximum in mature females. In males, both MK-801 affinity and maximum binding remain unchanged throughout development. This is the first report of gender differences in the association of NMDA receptors with neuroendocrine brain areas during development. It is also the first report to suggest NMDA receptor involvement in the development of the BPG axis in a nonmammalian vertebrate.
Subject(s)
Brain Chemistry/physiology , Brain/growth & development , Cyprinodontiformes/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Animals , Dizocilpine Maleate/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Female , Immunohistochemistry , Male , Models, Biological , Sex CharacteristicsABSTRACT
We have examined the distribution of the N-methyl-D-aspartate (NMDA) receptor in the brain of a freshwater teleost using an antibody against the R1 subunit of the receptor (NMDAR1). The primary site of localization was the nucleus olfactoretinalis (NOR), a significant gonadotropin releasing hormone (GnRH)-containing brain nucleus. The number of cells expressing NMDAR1 in this nucleus was dependent upon developmental stage, with pubescent and mature animals displaying significantly more stained cells than immature and senescent animals. This is the first reported observation of age- and maturity-related NMDA receptor association with GnRH-containing brain areas.
Subject(s)
Aging/metabolism , Brain/metabolism , Cyprinodontiformes/growth & development , Gene Expression Regulation, Developmental , Receptors, N-Methyl-D-Aspartate/biosynthesis , Animals , Brain/growth & development , Gonadotropin-Releasing Hormone/metabolism , Organ Specificity , Receptors, N-Methyl-D-Aspartate/analysisABSTRACT
Greenhouse mesocosms of freshwater marsh vegetation were exposed to a simulated saltwater intrusion event followed by a recovery period during which water levels and interstitial water salinity were adjusted over a range of conditions. Virtually all above-ground vegetation, including the three dominant species, Sagittaria lancifolia L., Leersia oryzoides (L.) Swartz, and Panicum hemitomon Schultes, was killed by the initial saltwater intrusion event. P. hemitomon did not recover, but S. lancifolia and L. oryzoides, as well as many of the other species initially present, exhibited some ability to recover depending on post-saltwater intrusion conditions. Increasingly harsh recovery conditions (for freshwater marsh vegetation), including more reduced soil conditions, higher interstitial salinities, and higher interstitial sulfide concentrations were associated with decreased live above-ground biomass and species richness. The effect of elevated salinity on vegetative recovery became more pronounced under flooded conditions. This experiment illustrates that the response of a freshwater marsh community to the long-term disturbance effect of a transient saltwater intrusion event will be strongly influenced by post-intrusion salinity and water levels.
ABSTRACT
A family with two members (two generations) exhibiting Turner syndrome is described. Cytogenetic studies on these individuals showed the presence of multiple X chromosome changes. Evidence is presented to show that the maternally inherited X chromosome is the chromosome involved in the structural alterations observed. The effect of a tendency of the maternal X chromosome to break at specific sites on the development of the Turner phenotype and abnormal karyology is discussed.
Subject(s)
Chromosome Aberrations , Ring Chromosomes , Turner Syndrome/genetics , X Chromosome/ultrastructure , Child, Preschool , Chromosome Banding , Female , Humans , Karyotyping , PedigreeABSTRACT
TSP-180 is a Mr 180,000 cell surface protein found on several murine lung carcinomas but not on fibroblast or sarcoma cell lines. Monoclonal antibody 135-13C binds to TSP-180 with high affinity but could not be used to quantitate the protein in tumors and normal tissue (Cancer Res., 41: 3465-3470, 1981). TSP-180 was purified from a transplantable BALB/c carcinoma (line 1 cells) by immunoaffinity chromatography and used as an immunogen to produce another monoclonal antibody (346-11A) to a different epitope on the molecule. A two-site solid-phase radioimmunoassay for TSP-180 was developed to quantitate TSP-180 in tissue extracts. The assay can detect as little as 3 ng of TSP-180 in samples up to 10 mg of protein. Analyses of several lung carcinoma cell lines confirmed that TSP-180 is present in all (five of five) cell lines ranging from 40 to 800 ng per mg of cell protein extract. Mouse tissues from normal and tumor-bearing mice were analyzed for TSP-180. Values for line 1 tumors growing i.m. were about 70 ng of TSP-180 per mg of protein. Normal tissue from normal and tumor-bearing mice contained low levels of TSP-180 from less than 0.3 ng/mg of protein for liver to a high of about 11 ng/mg of protein for leg muscle. Finally, small benign urethane-induced adenomas (1 to 2 mm) from BALB/c mice had moderate amounts of TSP-180 (11 ng/mg of protein), while two primary lung adenocarcinomas in the same animals had 20 and 47 ng/mg of protein, respectively, suggesting that TSP-180 expression may increase with increasing cancer of these tumors. Analyses of individual urethane-induced lung tumors from A/J mice showed that 11 of 13 carcinomas had high levels of TSP-180, while only 1 of 6 adenomas had a detectable amount of TSP-180, and that was at a moderate level. Specific quantitation of tumor markers in normal, benign, and malignant lung tissue may be helpful in identifying different levels of gene expression as tumors progress to more malignant states.
Subject(s)
Adenoma/immunology , Antigens, Neoplasm/analysis , Antigens, Surface/analysis , Carcinoma/immunology , Lung Neoplasms/immunology , Animals , Antibodies, Monoclonal , Antigens, Neoplasm/isolation & purification , Mice , Molecular Weight , Neoplasm Proteins/immunology , Neoplasm Proteins/metabolism , Tissue DistributionABSTRACT
We have developed a syngeneic monoclonal antibody (MoAb) (244-19A) which retards growth and contributes to cures of BALB/c mice bearing Moloney sarcoma cell (MSC) tumors (S.J. Kennel, T. Lankford, and K.M. Flynn, Cancer Res., 43: 2843-2847, 1983). The 244-19A epitope has not been detected in normal tissue or in any cultured cell (other than MSC) tested, including 15 different BALB/c sarcomas. MoAb 244-19A remains in circulation for a relatively long time in normal mice (t1/2 = 3.8 days), but it is cleared faster from tumor-bearing mice (t1/2 = 1.7 days), indicating a specific interaction of the antibody with the tumor. The 244-19A epitope is very labile. Osmotic lysis of cells or fixation with ethanol abolishes antibody binding. Trypsin treatment or fixation with gluteraldehyde reduces activity by 80 to 90%. Results from immunoprecipitation of radioiodinated MSC surface proteins indicate that the 244-19A epitope may reside on a Mr 65,000 protein, distinct from the major C-type virus glycoprotein 70 of these cells. Several factors affecting passive MoAb therapy have been evaluated. Doses as low as 24 micrograms/ mouse demonstrated a significant therapeutic effect; however, larger doses up to 1.5 mg/mouse produced progressively more cures. Since MoAb 244-19A is syngeneic in BALB/c mice, fractionated doses of antibody can be given over long periods of time without a host response to the MoAb. Fractionated doses showed a slight advantage over single dose therapy, but the difference was not statistically significant (P less than 0.2). Passive MoAb therapy has been effective in nu/nu mice, in BALB/c mice depleted of complement with cobra venum factor, and in BALB/c mice irradiated with 399 rads of X-rays; thus, therapy did not require complement, B-cells, or a cytotoxic T- cell response. Although tumor growth was retarded in nu/nu mice (T-cell-deficient), complete cures of tumored animals could not be accomplished even with large, multiple doses of antibody, indicating that cytotoxic T-cells eliminate residual tumor cells resulting in cures of BALB/c mice. Treatment of BALB/c mice with silica to deplete macrophage function did not affect therapy with MoAb 244-19A; however, treated animals still retained about 30% of their original phagocytic function, so macrophages cannot be eliminated as a possible host effector function.
Subject(s)
Antibodies, Monoclonal/therapeutic use , Immunization, Passive , Sarcoma, Experimental/therapy , Animals , Antibody-Dependent Cell Cytotoxicity , Antigens, Neoplasm/analysis , Complement System Proteins/immunology , Dose-Response Relationship, Drug , Epitopes/analysis , Iodine Radioisotopes , Mice , Mice, Inbred BALB C , Moloney murine sarcoma virus , Phagocytosis/radiation effects , Sarcoma, Experimental/immunologyABSTRACT
Syngeneic monoclonal antibodies (MoAb) to Moloney sarcoma cells (MSC) were produced by fusion of spleen cells from MSC regressor mice to myeloma SP2/0. MoAb 244-19A, an immunoglobulin G2b, bound to MSC cells and did not bind to two other sarcomas (K-BALB and Ha2), a carcinoma (Line 1), a fibroblast (A31) or a fibroblast infected with C-type virus (A31-Moloney leukemia virus). In contrast, MoAb 271-1A bound to the MSC and Ha2 sarcoma and line 1 carcinoma as well as to the normal and infected fibroblast cultures. Antibodies were tested for therapeutic effect using three schedules of antibody injection. Injection i.p. of ascites fluid containing 244-19A MoAb given on Days-1, 0, and +1 relative to tumor cell injection increased life span significantly over that of control animals given injections (P3, immunoglobulin G, or MoAb 271-1A) and produced some seven of 19, one of five, and one of five long-term survivors in three separate experiments. Antibody given to animals with established tumors (4 days after implantation) also prolonged life span significantly and produced three of nine long-term survivors. Antibody given to animals with very large tumor burdens (10 days after implantation) did not prolong life span significantly. Optimal dose, schedule, and mechanism studies concerning this therapy are in progress.